Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Avadel Pharmaceuticals (Nasdaq: AVDL) announced its management team will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2025, at 10:30 a.m. ET. The presentation will be available via webcast on the company's investor relations website at investors.avadel.com, with the recording remaining accessible for 90 days after the event.
Avadel Pharmaceuticals (Nasdaq: AVDL) ha annunciato che il suo team di gestione parteciperà a una conversazione informale durante la Jefferies Global Healthcare Conference il 5 giugno 2025 alle 10:30 ET. La presentazione sarà disponibile in webcast sul sito web per gli investitori dell'azienda all'indirizzo investors.avadel.com, con la registrazione accessibile per 90 giorni dopo l'evento.
Avadel Pharmaceuticals (Nasdaq: AVDL) anunció que su equipo directivo participará en una charla informal en la Jefferies Global Healthcare Conference el 5 de junio de 2025 a las 10:30 a.m. ET. La presentación estará disponible vía webcast en el sitio web de relaciones con inversores de la compañía en investors.avadel.com, y la grabación permanecerá accesible durante 90 días después del evento.
Avadel Pharmaceuticals (나스닥: AVDL) 경영진이 2025년 6월 5일 오전 10시 30분(동부시간)에 열리는 Jefferies Global Healthcare Conference에서 화상 대화에 참여할 예정이라고 발표했습니다. 발표는 회사 투자자 관계 웹사이트 investors.avadel.com에서 웹캐스트로 제공되며, 녹화본은 행사 후 90일간 시청할 수 있습니다.
Avadel Pharmaceuticals (Nasdaq : AVDL) a annoncé que son équipe de direction participera à une discussion informelle lors de la Jefferies Global Healthcare Conference le 5 juin 2025 à 10h30 ET. La présentation sera disponible en webcast sur le site des relations investisseurs de la société à l'adresse investors.avadel.com, avec un enregistrement accessible pendant 90 jours après l'événement.
Avadel Pharmaceuticals (Nasdaq: AVDL) gab bekannt, dass das Management-Team am 5. Juni 2025 um 10:30 Uhr ET an einem Gespräch im Rahmen der Jefferies Global Healthcare Conference teilnehmen wird. Die Präsentation wird per Webcast auf der Investor-Relations-Website des Unternehmens unter investors.avadel.com verfügbar sein, wobei die Aufzeichnung nach der Veranstaltung 90 Tage lang zugänglich bleibt.
- None.
- None.
DUBLIN, Ireland, May 29, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5 at 10:30 a.m. ET.
A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference.
About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years and older with narcolepsy. For more information, please visit www.avadel.com.
Investor Contact:
Austin Murtagh
Precision AQ
Austin.Murtagh@precisionAQ.com
(212) 698-8696
Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com
(609) 273-3162
FAQ
When is Avadel Pharmaceuticals (AVDL) presenting at the Jefferies Global Healthcare Conference 2025?
Where can I watch Avadel Pharmaceuticals' (AVDL) Jefferies conference presentation?
What type of presentation will Avadel Pharmaceuticals (AVDL) give at the Jefferies conference?
How long will Avadel Pharmaceuticals' (AVDL) Jefferies conference presentation be available online?
